EDITAS MEDICINE, INC. Shares Outstanding (Cover Page)
EDITAS MEDICINE, INC. (EDIT) had Shares Outstanding (Cover Page) of 153.58 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 153.58M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 97.91M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 97.87M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 97.62M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 153.58M shares 10-Q · filed 2026-08-05 |
| 2026-04-29 | 97.91M shares 10-Q · filed 2026-05-05 |
| 2026-02-27 | 97.87M shares 10-K · filed 2026-03-09 |
| 2025-10-31 | 97.62M shares 10-Q · filed 2025-11-10 |
| 2025-08-07 | 89.92M shares 10-Q · filed 2025-08-12 |
| 2025-05-07 | 83.71M shares 10-Q · filed 2025-05-12 |
| 2025-02-28 | 82.98M shares 10-K · filed 2025-03-05 |
| 2024-10-30 | 82.55M shares 10-Q · filed 2024-11-04 |
| 2024-08-02 | 82.48M shares 10-Q · filed 2024-08-07 |
| 2024-05-03 | 82.24M shares 10-Q · filed 2024-05-08 |
| 2024-02-23 | 81.81M shares 10-K · filed 2024-02-28 |
| 2023-10-27 | 81.67M shares 10-Q · filed 2023-11-03 |
| 2023-07-28 | 81.63M shares 10-Q · filed 2023-08-02 |
| 2023-04-28 | 69.00M shares 10-Q · filed 2023-05-05 |
| 2023-02-17 | 68.97M shares 10-K · filed 2023-02-22 |
| 2022-10-28 | 68.76M shares 10-Q · filed 2022-11-02 |
| 2022-07-29 | 68.74M shares 10-Q · filed 2022-08-03 |
| 2022-04-29 | 68.64M shares 10-Q · filed 2022-05-04 |
| 2022-02-14 | 68.52M shares 10-K · filed 2022-02-24 |
| 2021-11-05 | 68.40M shares 10-Q · filed 2021-11-09 |
| 2021-07-30 | 68.26M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 67.83M shares 10-Q · filed 2021-05-06 |
| 2021-02-14 | 67.36M shares 10-K · filed 2021-02-26 |
| 2020-10-30 | 62.33M shares 10-Q · filed 2020-11-06 |
| 2020-07-31 | 62.27M shares 10-Q · filed 2020-08-07 |
| 2020-05-01 | 55.00M shares 10-Q · filed 2020-05-08 |
| 2020-02-14 | 54.88M shares 10-K · filed 2020-02-26 |
| 2019-11-01 | 51.30M shares 10-Q · filed 2019-11-12 |
| 2019-08-01 | 49.52M shares 10-Q · filed 2019-08-07 |
| 2019-05-03 | 49.22M shares 10-Q · filed 2019-05-08 |
| 2019-02-08 | 49.09M shares 10-K · filed 2019-03-01 |
| 2018-10-31 | 47.81M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 47.68M shares 10-Q · filed 2018-08-07 |
| 2018-04-27 | 47.20M shares 10-Q · filed 2018-05-04 |
| 2018-02-28 | 46.88M shares 10-K · filed 2018-03-08 |
| 2017-10-31 | 42.12M shares 10-Q · filed 2017-11-08 |
| 2017-08-07 | 41.63M shares 10-Q · filed 2017-08-09 |
| 2017-05-05 | 41.35M shares 10-Q · filed 2017-05-15 |
| 2017-02-01 | 36.68M shares 10-K · filed 2017-03-03 |
| 2016-11-01 | 36.66M shares 10-Q · filed 2016-11-09 |
| 2016-08-01 | 36.61M shares 10-Q · filed 2016-08-10 |
| 2016-05-06 | 36.61M shares 10-Q · filed 2016-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |